Stebėti
Pablo Graván, PhD
Pablo Graván, PhD
Patvirtintas el. paštas ugr.es - Pagrindinis puslapis
Pavadinimas
Cituota
Cituota
Metai
Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment
P Graván, A Aguilera-Garrido, JA Marchal, SA Navarro-Marchal, ...
Advances in Colloid and Interface Science 314, 102871, 2023
612023
Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution
A Aguilera-Garrido, P Graván, SA Navarro-Marchal, M Medina-O’Donnell, ...
Biomedicine & Pharmacotherapy 163, 114828, 2023
112023
Exploring the impact of nanoparticle stealth coatings in cancer models: from PEGylation to cell membrane-coating nanotechnology
P Graván, J Peña-Martín, JL de Andrés, M Pedrosa, M Villegas-Montoya, ...
ACS Applied Materials & Interfaces 16 (2), 2058-2074, 2023
92023
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy
JL Blaya-Cánovas, C Griñán-Lisón, I Blancas, JA Marchal, ...
Molecular Cancer 23 (1), 83, 2024
32024
Towards a more efficient breast Cancer Therapy using active human cell membrane-coated metal–Organic frameworks
P Graván, S Rojas, DF Picchi, F Galisteo-González, P Horcajada, ...
Nanomaterials 14 (9), 784, 2024
22024
Effect of the Protein Corona Formation on Antibody Functionalized Liquid Lipid Nanocarriers
SA Navarro-Marchal, M Martín-Contreras, D Castro-Santiago, ...
International Journal of Molecular Sciences 24 (23), 16759, 2023
12023
047 Changes in proteome of membrane fractions from bovine oocyte to zygote
J Romero-Aguirregomezcorta, J Peña, P Graván, JG Hamzé, JA Marchal, ...
Animal-science proceedings 14 (3), 459-460, 2023
2023
Maslinic Acid Nanoparticles: a drug to carry others
P Graván, A Aguilera-Garrido, M Medina-O’Donell, A Parra, ...
Materials Proceedings 4 (1), 6, 2021
2021
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–8